We are live on ! Find out more
TNGX icon

Tango Therapeutics
TNGX

58 hedge funds and large institutions have $741M invested in Tango Therapeutics in 2021 Q4 according to their latest regulatory filings, with 18 funds opening new positions, 14 increasing their positions, 8 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

200% more first-time investments, than exits

New positions opened: 18 | Existing positions closed: 6

75% more repeat investments, than reductions

Existing positions increased: 14 | Existing positions reduced: 8

33% more funds holding in top 10

Funds holding in top 10: 3 → 4 (+1)

26% more funds holding

Funds holding: 46 → 58 (+12)

2.57% more ownership

Funds ownership: 74.84% → 77.41% (+2.6%)

12% less capital invested

Capital invested by funds: $844M → $741M (-$103M)

Holders
58
Holders Change
+12
Holders Change %
+26.09%
% of All Funds
0.89%
Holding in Top 10
4
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+33.33%
% of All Funds
0.06%
New
18
Increased
14
Reduced
8
Closed
6
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
CAM
Cormorant Asset Management
Massachusetts
+$12M
2
Fidelity Investments
Fidelity Investments
Massachusetts
+$11.2M
3
Janus Henderson Group
Janus Henderson Group
United Kingdom
+$6.46M
4
APM
Avidity Partners Management
Texas
+$4.87M
5
Geode Capital Management
Geode Capital Management
Massachusetts
+$1.91M

Top Sellers

Rank Fund Capital Flow
1
HA
HHLR Advisors
Cayman Islands
-$6.01M
2
RI
RTW Investments
New York
-$5.04M
3
Alyeska Investment Group
Alyeska Investment Group
Illinois
-$3.61M
4
BlackRock
BlackRock
New York
-$2.89M
5
SB
Samsara BioCapital
California
-$842K
Name Holding Trade Value Shares
Change 		Change in
Stake
Northern Trust
26
Northern Trust
Illinois
$1.36M +$137K +11,410 +10%
Alyeska Investment Group
27
Alyeska Investment Group
Illinois
$1.36M -$3.61M -300,300 -71%
Susquehanna International Group
28
Susquehanna International Group
Pennsylvania
$1.28M +$1.41M +116,880 New
Ensign Peak Advisors
29
Ensign Peak Advisors
Utah
$1.16M +$627K +52,156 +97%
NCM
30
Nantahala Capital Management
Connecticut
$1.09M – – –
Bank of America
31
Bank of America
North Carolina
$1.03M +$1.13M +93,848 +312,827%
Swiss National Bank
32
Swiss National Bank
Switzerland
$948K +$1.04M +86,700 New
Goldman Sachs
33
Goldman Sachs
New York
$904K +$993K +82,606 New
PVI
34
Pura Vida Investments
New York
$900K -$30.5K -2,535 -3%
ECM
35
ExodusPoint Capital Management
New York
$717K +$788K +65,501 New
Janney Montgomery Scott
36
Janney Montgomery Scott
Pennsylvania
$438K – – –
LP
37
LMR Partners
United Kingdom
$421K +$463K +38,459 New
JG
38
Jefferies Group
New York
$410K +$451K +37,483 New
California State Teachers Retirement System (CalSTRS)
39
California State Teachers Retirement System (CalSTRS)
California
$364K +$400K +33,250 New
JP Morgan Chase
40
JP Morgan Chase
New York
$357K +$369K +30,723 +1,696%
Citigroup
41
Citigroup
New York
$355K +$352K +29,273 +924%
AH
42
Aviva Holdings
Bahamas
$295K – – –
NFGH
43
Nan Fung Group Holdings
Hong Kong
$279K +$307K +25,500 New
Bank of New York Mellon
44
Bank of New York Mellon
New York
$276K – – –
Charles Schwab
45
Charles Schwab
California
$266K – – –
HF
46
HRT Financial
New York
$257K +$283K +23,517 New
CS
47
Credit Suisse
Switzerland
$256K +$282K +23,422 New
UBS AM
48
UBS AM
Illinois
$133K +$147K +12,200 New
OWP
49
Old Well Partners
North Carolina
$126K – – –
Legal & General Group
50
Legal & General Group
United Kingdom
$125K +$137K +11,397 New
1
2
3

TNGX Hedge Fund Activity: Q4 2021 in Review

58 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in Tango Therapeutics (TNGX) for Q4 2021, worth a combined $741M — down 12% from $844M a quarter earlier.

Buyers outnumbered sellers: 18 funds opened new TNGX positions and 6 closed out — a net gain of 12 holders — while 14 added to existing stakes and 8 trimmed.

The largest buyer was Cormorant Asset Management, adding an estimated $12M. The largest seller was HHLR Advisors, cutting an estimated $6.01M.

  • 58 institutional investors held Tango Therapeutics (TNGX) as of Q4 2021, up from 46 in Q3 2021.
  • Funds reported $741M of Tango Therapeutics stock for Q4 2021, down 12% quarter-over-quarter.
  • 18 funds opened new Tango Therapeutics positions in Q4 2021 and 6 closed out, a net change of +12 holders.
  • The largest Tango Therapeutics buyer in Q4 2021 was Cormorant Asset Management, an estimated $12M added.
  • The largest Tango Therapeutics seller in Q4 2021 was HHLR Advisors, an estimated $6.01M sold.

Based on aggregated 13F filings for Q4 2021.